Fluid Lavage of Open Wounds (FLOW)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00788398 |
Recruitment Status :
Completed
First Posted : November 10, 2008
Last Update Posted : February 11, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Open Fracture Wounds | Procedure: Saline Solution Procedure: Soap solution Procedure: Gravity Flow Irrigation Procedure: Low Pressure Irrigation Procedure: High Pressure | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 2540 participants |
Allocation: | Randomized |
Intervention Model: | Factorial Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Fluid Lavage of Open Wounds (FLOW): A Multi-center, Blinded, Factorial Trial Comparing Alternative Irrigating Solutions and Pressures in Patients With Open Fractures |
Study Start Date : | June 2009 |
Actual Primary Completion Date : | January 2015 |
Actual Study Completion Date : | April 2015 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Saline, gravity flow |
Procedure: Saline Solution
Irrigation with Saline Procedure: Gravity Flow Irrigation Gravity flow irrigation will be standardized across participating centers as 3L bags of normal saline (alone or with soap solution) suspended 6-8 feet above floor level using an I.V. pole. Irrigation tubing (measuring 1/4 - 3/8 inch inner diameter) will be connected to the 3L bag and secured with a stopcock (or compressive device) until ready for use. |
Active Comparator: Saline, Low Pressure |
Procedure: Saline Solution
Irrigation with Saline Procedure: Low Pressure Irrigation Irrigation with the Stryker SurgiLav System. At the low pressure setting delivers 5.9 p.s.i. pressure. The high-flow irrigator tip will be held perpendicular to and 5cm above the wound. Irrigation with the Zimmer PulsaVac. For low pressure delivery, the shower tip will be used at the low pressure setting which delivers a pressure of 5.8 p.s.i. |
Active Comparator: Saline, High Pressure |
Procedure: Saline Solution
Irrigation with Saline Procedure: High Pressure Irrigation with the Stryker SurgiLav System. For the high pressure delivery, the multi-orifice tip will be used at the high setting which delivers a pressure of 30 p.s.i. Irrigation with the Zimmer PulsaVac System: For the high pressure delivery the shower tip will be used at the high pressure setting which delivers a pressure of 23 p.s.i. |
Active Comparator: Soap, Gravity Flow |
Procedure: Soap solution
Irrigation with Castile Soap Solution (80 ml per 3L bag of saline) Procedure: Gravity Flow Irrigation Gravity flow irrigation will be standardized across participating centers as 3L bags of normal saline (alone or with soap solution) suspended 6-8 feet above floor level using an I.V. pole. Irrigation tubing (measuring 1/4 - 3/8 inch inner diameter) will be connected to the 3L bag and secured with a stopcock (or compressive device) until ready for use. |
Active Comparator: Soap, low pressure |
Procedure: Soap solution
Irrigation with Castile Soap Solution (80 ml per 3L bag of saline) Procedure: Low Pressure Irrigation Irrigation with the Stryker SurgiLav System. At the low pressure setting delivers 5.9 p.s.i. pressure. The high-flow irrigator tip will be held perpendicular to and 5cm above the wound. Irrigation with the Zimmer PulsaVac. For low pressure delivery, the shower tip will be used at the low pressure setting which delivers a pressure of 5.8 p.s.i. |
Active Comparator: Soap, high pressure |
Procedure: Soap solution
Irrigation with Castile Soap Solution (80 ml per 3L bag of saline) Procedure: High Pressure Irrigation with the Stryker SurgiLav System. For the high pressure delivery, the multi-orifice tip will be used at the high setting which delivers a pressure of 30 p.s.i. Irrigation with the Zimmer PulsaVac System: For the high pressure delivery the shower tip will be used at the high pressure setting which delivers a pressure of 23 p.s.i. |
- Re-operation within 12 months post initial surgery to treat an infection, manage a wound healing problem, or promote fracture healing. [ Time Frame: within 12 months ]
- Patient function and quality of life measured by the Short Form-12 (SF-12) and the EuroQol-5D [ Time Frame: 12 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 14 Years to 85 Years (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Men or women who are skeletally mature.
- Fracture of any extremity with complete radiographs.
- Open fractures (Gustilo-Anderson Types I-IIIB) (Table 2)*.
- Fracture requiring operative fixation.
- Provision of informed consent.
Exclusion Criteria:
- Open fractures with an associated vascular deficit (Gustilo-Anderson Type IIIC).
- Known allergy to detergents or castile soap ingredients.
- Previous wound infection or history of osteomyelitis in the injured extremity.
- Previous fracture with retained hardware in injured extremity that will interfere with new implant fixation.
- Surgical delay to operative wound management greater than 24 hours from hospital admission.
- Use of immunosuppressive medication within 6 months.
- Immunological deficient disease conditions (e.g. HIV).
- Fracture of the hand (metacarpals and phalanges).
- Fracture of the toes (phalanges).
- Likely problems, in the judgment of the investigators, with maintaining follow-up. We will, for example, exclude patients with no fixed address, those who report a plan to move out of town in the next year, or intellectually challenged patients without adequate family support.
- Previous randomization in this study or a competing study.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00788398

Principal Investigator: | Kyle J. Jeray, MD | Greenville Hospital System | |
Principal Investigator: | Bradley Petrisor, MD | Hamilton Health Sciences Corporation | |
Principal Investigator: | Mohit Bhandari, MD | McMaster University | |
Principal Investigator: | Gordan Guyatt, M.D. | McMaster University |
Responsible Party: | Prisma Health-Upstate |
ClinicalTrials.gov Identifier: | NCT00788398 |
Other Study ID Numbers: |
GHS-03-08-06 W81XWH-08-1-0473 |
First Posted: | November 10, 2008 Key Record Dates |
Last Update Posted: | February 11, 2016 |
Last Verified: | February 2016 |
Wounds and Injuries Fractures, Open Fractures, Bone Pharmaceutical Solutions |